TET2 binding, a factor strongly linked to myeloid malignancies, was found to associate specifically with proliferation DMRs and ALL specific DMRs (supplementary Fig. 5), suggesting a potential role for TET2 in ALL specific methylation changes. Here, TET2 is linked to acute lymphoblastic leukemia.